In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.
They look at how biosimilars are changing healthcare and what the market looks like today, as well as Sandoz’s involvement in the area and the company’s future plans in biosimilars.
It’s an episode that covers the regulatory position of biosimilars, uptake of these medicines by healthcare professionals and what biosimilars need next.
You can listen to episode 44 of the pharmaphorum podcast in the player below, download the episode to your computer or find it – and subscribe to the rest of the series in iTunes, Spotify, acast, Stitcher and Podbean.
The post Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast appeared first on .
